Josh Genuth, Author at PsyNews.com

Home Authors Posts by Watertime

255 POSTS 0 COMMENTS

Why Isn’t Big Pharma Jumping Into Psychedelics?

So, You Want to Participate in a Psychedelic Clinical Trial

This is the Difference Between Psilocybin and LSD

How Psychedelics Can Treat PTSD

The Future of MDMA Therapy: Promising Next Steps

How Red Light Holland Is Bringing Psilocybin Truffles Mainstream

5-MeO-DMT: Can ‘Toad Juice’ Cure Depression?

Interview With Yaron Conforti, Novamind

Interview With Dr. Hyder A. Khoja

2 Massachusetts Cities Have Decriminalized Psychedelics in the Last Month

1...202122...26 Page 21 of 26

Advanced Shadow Work and Psychedelic Integration: A Jungian Path to Wholeness

Essentials of Psychedelic Therapy & Integration

Pα+ Psychedelic Bulletin #206: Q2’25 Psychedelic Lobbying; Tabernanthalog’s Neuroplasticity Pathway; UK...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Watertime